Shopping Cart
- Remove All
 
Your shopping cart is currently empty
PROTAC TTK Degrader-2 is a potent threonine tyrosine kinase (TTK) PROTAC degrader, achieving DC50 values of 3.1 nM in COLO-205 cells and 12.4 nM in HCT-116 cells. It demonstrates effective target degradation and anticancer activity in a COLO-205 human colorectal cancer cell xenograft mouse model [1].

| Pack Size | Price | Availability | Quantity | 
|---|---|---|---|
| 5 mg | Inquiry | Backorder | |
| 50 mg | Inquiry | Backorder | 
| Description | PROTAC TTK Degrader-2 is a potent threonine tyrosine kinase (TTK) PROTAC degrader, achieving DC50 values of 3.1 nM in COLO-205 cells and 12.4 nM in HCT-116 cells. It demonstrates effective target degradation and anticancer activity in a COLO-205 human colorectal cancer cell xenograft mouse model [1].  | 
| In vitro | PROTAC TTK degrader-2 (compound 8j), at concentrations from 0 to 10 μM over 96 hours, inhibits cancer cell proliferation [1].  | 
| In vivo | PROTAC TTK degrader-2 (8j) administered intraperitoneally at 10 mg/kg exhibits satisfactory pharmacokinetic profiles [1]. Daily intraperitoneal dosing of 10 or 20 mg/kg for 16 days significantly reduces TTK protein levels and suppresses tumor growth [1]. Pharmacokinetic parameters for PROTAC TTK degrader-2 were established in male SD rats [1].  | 
| Molecular Weight | 884.03 | 
| Formula | C49H57N9O7 | 
| Cas No. | 2953426-48-5 | 
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.